The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I safety study of topical calcitriol (BPM 31543) for the prevention of chemotherapy-induced alopecia (CIA).
 
Mario E. Lacouture
Consulting or Advisory Role - Adgero Biopharmaceuticals; AstraZeneca; Berg Pharma; Boehringer Ingelheim; Bristol-Myers Squibb; Foamix; Janssen Research & Development; Legacy Healthcare Services; Novartis; Novocure; Quintiles
Research Funding - Berg Pharma; Bristol-Myers Squibb
 
Jason A. Konner
Consulting or Advisory Role - Clovis Oncology; Genentech/Roche
Research Funding - AstraZeneca/MedImmune; Genentech/Roche; TapImmune Inc.
 
Viswanath Reddy Belum
No Relationships to Disclose
 
Janice Stevens
Employment - Berg Pharma
Travel, Accommodations, Expenses - Berg Pharma
 
Hedy Dion
Employment - Berg Pharma
Stock and Other Ownership Interests - Berg Pharma
 
Kathryn Ciccolini
Consulting or Advisory Role - Roche
 
Sarah Kitts
No Relationships to Disclose
 
Ran Ye
Employment - Berg Pharma
 
Shobha Ravipaty
Employment - Berg Pharma
 
Viacheslav R Akmaev
Employment - Berg Pharma
Leadership - Berg Pharma
Stock and Other Ownership Interests - Berg Pharma
Patents, Royalties, Other Intellectual Property - Berg Pharma
Travel, Accommodations, Expenses - Berg Pharma
 
Rangaprasad Sarangarajan
Employment - Berg Pharma
Leadership - Berg Pharma
Stock and Other Ownership Interests - Berg Pharma
Research Funding - Berg Pharma
Patents, Royalties, Other Intellectual Property - Berg Pharma
Travel, Accommodations, Expenses - Berg Pharma
 
Joaquin Juan Jimenez
No Relationships to Disclose
 
Niven R. Narain
Employment - Berg Pharma
Leadership - Berg Pharma
Stock and Other Ownership Interests - Berg Pharma
Patents, Royalties, Other Intellectual Property - Berg Pharma
Travel, Accommodations, Expenses - Berg Pharma
 
Brian Berman
Leadership - Celumigen
Stock and Other Ownership Interests - Berg Pharma; Celumigen; Halscion
Honoraria - Aclaris Therapeutics; Anacor; Aviva; Berg Pharma; Biofrontera; Celumigen; Clark Pharmaceutical; Dermira; DUSA Pharmaceuticals, Inc.; Exeltis; Ferndale Pharma Group; Galderma; Galderma; GlaxoSmithKline; Halscion; LEO Pharma; Medimetriks Pharmaceuticals; Menlo Therapeutics; Miragen; Novacea; Novartis; Pulse; Sensus; Smith & Nephew; sonoma pharmaceuticals ; TopMD; Valeant Pharmaceuticals International
Consulting or Advisory Role - Aclaris Therapeutics; Anacor; Aviva; Berg Pharma; Biofrontera; Celumigen; Clark Pharmaceutical; Dermira; DUSA Pharmaceuticals, Inc.; Exeltis; Ferndale Pharma Group; Galderma; Galderma; GlaxoSmithKline; Halscion; LEO Pharma; Medimetriks Pharmaceuticals; Menlo Therapeutics; miRagen; Novacea; Novartis; Pulse; Sensus; Smith & Nephew; sonoma pharmaceuticals ; TopMD; Valeant Pharmaceuticals International
Speakers' Bureau - Aclaris Therapeutics; Anacor; Aviva; Berg Pharma; Biofrontera; Celumigen; Clark Pharmaceutical; Dermira; DUSA Pharmaceuticals, Inc.; Exeltis; Ferndale Pharma Group; Galderma; Galderma; GlaxoSmithKline; Halscion; LEO Pharma; Medimetriks Pharmaceuticals; Menlo Therapeutics; miRagen; Novacea; Novartis; Pulse; Sensus; Smith & Nephew; sonoma pharmaceuticals ; TopMD; Valeant Pharmaceuticals International
Research Funding - Aclaris Therapeutics; Anacor; Aviva; Berg Pharma; Biofrontera; Celumigen; Clark Pharmaceutical; Dermira; DUSA Pharmaceuticals, Inc.; Exeltis; Ferndale Pharma Group; Galderma; Galderma; GlaxoSmithKline; Halscion; LEO Pharma; Medimetriks Pharmaceuticals; Menlo Therapeutics; miRagen; Novacea; Novartis; Pulse; Sensus; Smith & Nephew; sonoma pharmaceuticals ; TopMD; Valeant Pharmaceuticals International
 
Shari Beth Goldfarb
Consulting or Advisory Role - Sermonix Pharmaceuticals
Research Funding - Paxman